2024. Pyrotinib: A promising Tyrosine Kinase Inhibitor for treating Breast Cancer. Molecular Medicine Communications. 4, 01 (Jun. 2024), 43–57. DOI:https://doi.org/10.55627/mmc.004.001.0553.